What is the price target for ALVAL stock?
11 analysts have analysed ALVAL.PA and the average price target is 2.18 EUR. This implies a price increase of 115.44% is expected in the next year compared to the current price of 1.01.
EPA:ALVAL • FR0013254851
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VALBIOTIS SA (ALVAL.PA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-03 | MIDCAP PARTNERS | Maintains | Buy -> Buy |
| 2026-01-26 | PORTZAMPARC BNP PARIBAS | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.733M 502.93% | 175K -96.30% | 905K 417.14% | 4.996M 452.04% | 15.862M 217.49% | N/A | N/A | N/A | N/A | N/A | |
| EBITDA YoY % growth | -6.444M 42.33% | -9.836M -52.64% | -9.198M 6.49% | -7.365M 19.93% | -927K 87.41% | 4.902M 628.80% | 12.394M 152.84% | 13.134M 5.97% | 16.094M 22.54% | 18.683M 16.09% | |
| EBIT YoY % growth | -7.18M 40.30% | -10.423M -45.17% | -9.494M 8.91% | -6.077M 35.99% | -618K 89.83% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | -151.70% | -5,956.00% | -1,049.06% | -121.64% | -3.90% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A 38.29% | N/A -2.92% | N/A 34.34% | -0.35 26.09% | -0.05 85.29% | N/A | N/A | N/A | N/A | N/A |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
11 analysts have analysed ALVAL.PA and the average price target is 2.18 EUR. This implies a price increase of 115.44% is expected in the next year compared to the current price of 1.01.
The consensus rating for VALBIOTIS SA (ALVAL.PA) is 85.4545 / 100 . This indicates that analysts generally have a positive outlook on the stock.